Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Reid

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Journal of Cardiovascular Pharmacology|July 15, 2011
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive ratsAbishek Iyer, Trent M Woodruff, Mike C L Wu, et al.
The Journal of Biological Chemistry|December 13, 2006
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand bindingAnne-Marie Scola, Adrian Higginbottom, Lynda J Partridge, et al.
The Biochemical Journal|October 7, 2024
Histone deacetylase 7 activates 6-phosphogluconate dehydrogenase via an enzyme-independent mechanism that involves the N-terminal protein-protein interaction domainYizhuo Wang, James E B Curson, Divya Ramnath, et al.
Journal of Medicinal Chemistry|January 11, 2002
Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activityMatthew P Glenn, Leonard K Pattenden, Robert C Reid, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2010
Inhibitors selective for HDAC6 in enzymes and cellsPraveer K Gupta, Robert C Reid, Ligong Liu, et al.
Chemical Communications (Cambridge, England)|February 15, 2013
Efficient chemical synthesis of human complement protein C3aArtin Ghassemian, Ching-I Anderson Wang, Mei-Kwan Yau, et al.
Medicinal Research Reviews|May 26, 2026
Hydroxamic Acids as HDAC Inhibitor Drug Leads for MalariaWisam A Dawood, Jacinta R Macdonald, Christian Anzenhofer, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 28, 2016
Histone deacetylase enzymes as drug targets for the control of the sheep blowfly, Lucilia cuprinaAndrew C Kotze, Barney M Hines, Neil H Bagnall, et al.
International Immunopharmacology|March 22, 2005
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitisTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2015
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat ArthritisRink-Jan Lohman, Abishek Iyer, Thomas J Fairlie, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Cardiovascular Pharmacology|July 15, 2011
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive ratsAbishek Iyer, Trent M Woodruff, Mike C L Wu, et al.
The Journal of Biological Chemistry|December 13, 2006
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand bindingAnne-Marie Scola, Adrian Higginbottom, Lynda J Partridge, et al.
The Biochemical Journal|October 7, 2024
Histone deacetylase 7 activates 6-phosphogluconate dehydrogenase via an enzyme-independent mechanism that involves the N-terminal protein-protein interaction domainYizhuo Wang, James E B Curson, Divya Ramnath, et al.
Journal of Medicinal Chemistry|January 11, 2002
Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activityMatthew P Glenn, Leonard K Pattenden, Robert C Reid, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2010
Inhibitors selective for HDAC6 in enzymes and cellsPraveer K Gupta, Robert C Reid, Ligong Liu, et al.
Chemical Communications (Cambridge, England)|February 15, 2013
Efficient chemical synthesis of human complement protein C3aArtin Ghassemian, Ching-I Anderson Wang, Mei-Kwan Yau, et al.
Medicinal Research Reviews|May 26, 2026
Hydroxamic Acids as HDAC Inhibitor Drug Leads for MalariaWisam A Dawood, Jacinta R Macdonald, Christian Anzenhofer, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 28, 2016
Histone deacetylase enzymes as drug targets for the control of the sheep blowfly, Lucilia cuprinaAndrew C Kotze, Barney M Hines, Neil H Bagnall, et al.
International Immunopharmacology|March 22, 2005
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitisTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2015
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat ArthritisRink-Jan Lohman, Abishek Iyer, Thomas J Fairlie, et al.
Pageof 8